Abstract Changes in the glycosylation process appear early in carcinogenesis and evolve
with the growth and spread of cancer. The correlation of the characteristic glycosylation …

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths
worldwide with the incidence of recurrence being as high as 88% even among patients who …

Purpose To evaluate the efficacy and safety of lenvatinib plus programmed death-1 (PD-1)
antibody as postoperative adjuvant therapy in patients with hepatocellular carcinoma (HCC) …

Background and Objective With the development of novel active systemic therapies, the
landscape of hepatocellular carcinoma (HCC) management is rapidly changing. However …

Background & Aims Metabolic syndrome (MS) is a growing epidemic and a risk factor for the
development of hepatocellular carcinoma (HCC). This study investigated the long-term …

Hepatocellular carcinoma (HCC), the sixth most common cancer globally, is associated with
high mortality rates and more than 830,000 annual deaths. Despite advances in the …

Background Disulfidptosis is an emerging form of cellular death resulting from the binding of
intracellular disulfide bonds to actin cytoskeleton proteins. This study aimed to investigate …

Hepatocellular carcinoma (HCC) is a malignancy known for its unfavorable prognosis. The
dysregulation of the tumor microenvironment (TME) can affect the sensitivity to …

Background sFrailty affects short-term outcomes after liver resection in elderly patients.
However, frailty's effects on long-term outcomes after liver resection in elderly patients with …

Background Hepatocellular carcinoma (HCC) represents a considerable burden to patients
and health systems. Microvascular invasion (MVI) is a significant risk factor for HCC …